UNSPSC 51192309: Chromic chloride/cupric chloride/manganese sulfate/selenium/zinc

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN490. This VA Drug Class (TN490) classifies this compound as belonging to the group ELECTROLYTES/MINERALS, COMBINATIONS.

UNSPSC 51192309 Chromic chloride/cupric chloride/manganese sulfate/selenium/zinc is a Commodity code that state and local governments use to procure specialty chemicals and pharmaceutical ingredients for water treatment, healthcare, and operational support functions. Recent solicitations show the code capturing municipal chemical supply for water pollution control facilities and multi-source pharmaceutical and over-the-counter product procurement across state and local health systems. The issuing bodies are primarily municipalities and multi-jurisdictional cooperative purchasing alliances administering contracts for networks of state and local facilities. Work solicited includes unit-priced chemical supply contracts with detailed product specifications, delivery schedules, and compliance documentation, as well as pharmaceutical product supply arrangements requiring manufacturers to provide comprehensive pricing data against authorized wholesale distribution channels.

Activity concentrates in Connecticut and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, driving significant multi-state reach including Oregon participation. Representative opportunities include the City of Meriden's IFB B027-15 for sodium bisulfite chemical supply to its Water Pollution Control Facility with bids due July 29, 2026, and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, under which awarded vendors must be available through AmerisourceBergen Drug Corporation, Cardinal Health, or Morris & Dickson Co., LLC by May 15, 2026 and become effective July 1, 2026. Both solicitations require comprehensive insurance coverage, compliance certification (Connecticut-approved carriers in Meriden's case; FDA and cGMP compliance in MMCAP's), and performance bonds or administrative fee structures.